http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5232932-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b8f83efcd29cf727e8bde08e0bcd4d6c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4418
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4406
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-38
filingDate 1992-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1993-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6da70d61fb6af31c8cdd3fc8e9f2aa02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_825c803660b83b83281842260fde2bb7
publicationDate 1993-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-5232932-A
titleOfInvention Method for treatment of neurodegenerative diseases
abstract Patients suffering from neurodegenerative diseases are treated by administering an effective amount of a pseudooxynicotine compound.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004167179-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7074812-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5977144-A
priorityDate 1992-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3870794-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5015741-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4863930-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4765985-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0316718-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0377520-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4442292-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4965074-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4578394-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4342762-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395454
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID681
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID223739297
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID434
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399686
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129261209
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405549
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17828881
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129093846
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71420
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID231247505
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54670067
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID187
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID942
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409750
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4688
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136230068
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136302919
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409751
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID89594
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24749
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394438
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396427
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394880
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394612
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID223748217
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID223739294
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23831
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25200375
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23830

Total number of triples: 62.